Liaoning Financial Statements From 2010 to 2024

688739 Stock   27.32  0.43  1.60%   
Liaoning Chengda financial statements provide useful quarterly and yearly information to potential Liaoning Chengda Biotechnology investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Liaoning Chengda financial statements helps investors assess Liaoning Chengda's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Liaoning Chengda's valuation are summarized below:
Gross Profit
1.6 B
Profit Margin
0.1933
Market Capitalization
11.4 B
Enterprise Value Revenue
3.5147
Revenue
1.7 B
We have found fourty-nine available fundamental ratios for Liaoning Chengda, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Liaoning Chengda last-minute market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

Liaoning Chengda Total Revenue

1.49 Billion

Check Liaoning Chengda financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Liaoning Chengda's main balance sheet or income statement drivers, such as Tax Provision of 102.7 M, Net Interest Income of 73.4 M or Interest Income of 75.4 M, as well as many indicators such as . Liaoning financial statements analysis is a perfect complement when working with Liaoning Chengda Valuation or Volatility modules.
  
This module can also supplement various Liaoning Chengda Technical models . Check out the analysis of Liaoning Chengda Correlation against competitors.

Liaoning Chengda Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.4 B10.1 B5.3 B
Slightly volatile
Other Current Liabilities628661956.5 K
Slightly volatile
Total Current Liabilities292.4 M356.8 M214.6 M
Slightly volatile
Total Stockholder EquityB9.6 BB
Slightly volatile
Retained Earnings3.7 BB2.6 B
Slightly volatile
Accounts Payable146.5 M215.1 M99.8 M
Slightly volatile
Cash3.4 B4.5 BB
Slightly volatile
Non Current Assets Total2.2 B2.8 B1.5 B
Slightly volatile
Non Currrent Assets Other181.4 M120.2 M163.2 M
Pretty Stable
Net Receivables920.6 M1.1 B653.5 M
Slightly volatile
Common Stock Shares Outstanding439.8 M478.9 M391.6 M
Slightly volatile
Short Term Investments1.4 B1.3 B556.4 M
Slightly volatile
Non Current Liabilities Total112.1 M125.4 M134.1 M
Very volatile
Inventory401 M422.4 M300.4 M
Slightly volatile
Other Current Assets57.5 M60.5 M340.9 M
Slightly volatile
Total Liabilities446.5 M482.2 M351.5 M
Slightly volatile
Net Invested CapitalB9.6 BB
Slightly volatile
Total Current Assets6.2 B7.2 B3.8 B
Slightly volatile
Capital Stock439.8 M478.9 M391.6 M
Slightly volatile
Non Current Liabilities Other14.3 K12.4 K11.3 K
Slightly volatile
Net Working Capital5.9 B6.9 B3.6 B
Slightly volatile
Intangible Assets295.8 M542.3 M185 M
Slightly volatile
Property Plant And Equipment Net1.6 B1.9 B1.2 B
Slightly volatile
Capital Lease Obligations16 M15.1 M23.5 M
Slightly volatile
Property Plant And Equipment Gross2.2 B2.7 B1.7 B
Slightly volatile
Short and Long Term Debt4.9 M4.9 M4.1 M
Slightly volatile

Liaoning Chengda Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision102.7 M110.5 M123.9 M
Pretty Stable
Net Interest Income73.4 M69.9 M24.5 M
Slightly volatile
Interest Income75.4 M71.8 M25.8 M
Slightly volatile
Selling General Administrative452.6 M476.1 M382.4 M
Slightly volatile
Total Revenue1.5 B1.8 B1.7 B
Pretty Stable
Gross Profit1.3 B1.5 B1.5 B
Pretty Stable
Operating Income667.8 M592.7 M795.2 M
Very volatile
Net Income From Continuing Ops590.2 M465.9 M704.3 M
Very volatile
Research Development230 M220.5 M177 M
Slightly volatile
EBITDA1.1 B1.1 B928.9 M
Slightly volatile
Cost Of Revenue274.2 M286.2 M245.4 M
Slightly volatile
Total Operating Expenses1.1 B1.2 B952.8 M
Slightly volatile
Reconciled Depreciation109 M125.3 M81.2 M
Slightly volatile
Income Before Tax692.9 M576.4 M828.2 M
Very volatile
Net Income590.2 M465.9 M704.3 M
Very volatile
Interest Expense1.1 M1.4 M1.5 M
Slightly volatile

Liaoning Chengda Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow6.1 B5.8 B1.9 B
Slightly volatile
Depreciation109 M125.3 M81.2 M
Slightly volatile
Other Non Cash Items1.8 M2.4 M909.8 K
Slightly volatile
Dividends Paid352.7 M416.3 M271.7 M
Slightly volatile
Capital Expenditures488.8 M552 M457.6 M
Very volatile
Total Cash From Operating Activities530.1 M677 M690.6 M
Slightly volatile
Net Income590.2 M465.9 M704.3 M
Very volatile
End Period Cash Flow3.4 B4.5 BB
Slightly volatile

About Liaoning Chengda Financial Statements

Liaoning Chengda stakeholders use historical fundamental indicators, such as Liaoning Chengda's revenue or net income, to determine how well the company is positioned to perform in the future. Although Liaoning Chengda investors may analyze each financial statement separately, they are all interrelated. For example, changes in Liaoning Chengda's assets and liabilities are reflected in the revenues and expenses on Liaoning Chengda's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Liaoning Chengda Biotechnology. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue1.8 B1.5 B
Cost Of Revenue286.2 M274.2 M

Currently Active Assets on Macroaxis

Other Information on Investing in Liaoning Stock

Liaoning Chengda financial ratios help investors to determine whether Liaoning Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Liaoning with respect to the benefits of owning Liaoning Chengda security.